Status:
RECRUITING
Optimization of the Skin Test Procedure With Iodinated Contrast Products for Certain Patients Suspected of Immediate Hypersensitivity
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Contrast Sensitivity
Eligibility:
All Genders
18+ years
Brief Summary
Hypersensitivity to iodinated contrast products (ICP) affects 1 to 3% of injected patients. These reactions require an allergological assessment with skin tests in order to distinguish allergic immuno...
Eligibility Criteria
Inclusion
- Major subject (≥18 years old)
- Subject treated in the allergology department in the period from June 1, 2020 to July 3, 2023 for suspected allergic hypersensitivity to ICPs and having had at least one undiluted intradermal reaction to one or more ICPs.
- Absence of written opposition in the medical file of the subject (and/or their legal representative if applicable) to the reuse of their data for scientific research purposes.
Exclusion
- Presence of opposition from the subject (and/or their legal representative if applicable) to the reuse of their data for scientific research purposes.
Key Trial Info
Start Date :
December 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06498219
Start Date
December 21 2023
End Date
December 31 2024
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pneumologie - CHU de Strasbourg - France
Strasbourg, France, 67091